HomeNewsTechnologyThese are the technologies that will revolutionise businesses in the Post-COVID era

These are the technologies that will revolutionise businesses in the Post-COVID era

In the post-COVID–19 business landscape, technologies will play a critical role in enabling enterprises to create scalable business impact and design highly personalised offerings.

June 22, 2020 / 19:08 IST
Story continues below Advertisement

Tulika Saxena

COVID–19 has highlighted the importance of technology-led transformation across industries. The coming decade is expected to witness a transformation catalysed by the emergence and confluence of variety of technologies.

Story continues below Advertisement

How has COVID–19 changed the status quo?

Biologists Stephen Gould’s and Niles Eldredge’s punctuated equilibrium theory states that evolutionary change happens in short, stressful bursts of time. We can consider these ‘brief moments’ akin to a revolution that drives a much-needed transformation. The entities that can undertake such a transformation succeed in the new normal.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show